The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.09BCNY
1.06B · vs all stocks (USD)
Updated Oct 23, 2026
Revenue (TTM)
6.04BCNY
904.65M · vs all stocks (USD)
Updated Oct 23, 2026
Profit Margin
-16.10%
vs Medical Care Facilities peers
Updated Oct 23, 2026
Beta
0.0830x
vs all stocks
Updated Oct 23, 2026
52-Week Change
-29.84%
vs all stocks
Updated Oct 23, 2026
Market Capitalization
7.09BCNY
1.06B · vs all stocks (USD)
Updated Oct 23, 2026
Enterprise Value
3.79BCNY
567.04M · vs all stocks (USD)
Updated Oct 23, 2026
Forward P/E
10.54x
vs Medical Care Facilities peers
Updated Oct 23, 2026
Price to Sales (TTM)
1.17x
vs Medical Care Facilities peers
Updated Oct 23, 2026
Price to Book (MRQ)
0.4330x
vs Medical Care Facilities peers
Updated Oct 23, 2026
Enterprise to Revenue
0.6270x
vs Medical Care Facilities peers
Updated Oct 23, 2026
Enterprise to EBITDA
9.46x
vs Medical Care Facilities peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 4.21×.Updated Oct 23, 2026
Gross Margin
34.71%
vs Medical Care Facilities peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 37.02%.Updated Oct 23, 2026
Profit Margin
-16.10%
vs Medical Care Facilities peers
Updated Oct 23, 2026
Operating Margin
2.59%
vs Medical Care Facilities peers
Updated Oct 23, 2026
Return on Assets (TTM)
0.37%
vs Medical Care Facilities peers
Updated Oct 23, 2026
Return on Equity (TTM)
-4.55%
vs Medical Care Facilities peers
Updated Oct 23, 2026
Revenue (TTM)
6.04BCNY
904.65M · vs all stocks (USD)
Updated Oct 23, 2026
Revenue per Share (TTM)
4.87CNYUpdated Oct 23, 2026
Quarterly Revenue Growth
-10.90%
vs Medical Care Facilities peers
Updated Oct 23, 2026
Gross Profit (TTM)
2.24BCNY
334.88M · vs all stocks (USD)
Updated Oct 23, 2026
EBITDA (TTM)
898.58MCNY
134.61M · vs all stocks (USD)
Updated Oct 23, 2026
Net Income (TTM)
-972.27MCNY
-145.65M · vs all stocks (USD)
Updated Oct 23, 2026
Quarterly Earnings Growth (YoY)
-86.30%
vs Medical Care Facilities peers
Updated Oct 23, 2026
Operating Cash Flow (TTM)
552.86MCNY
82.82M · vs all stocks (USD)
Updated Oct 23, 2026
Levered Free Cash Flow (TTM)
423.71MCNY
63.47M · vs all stocks (USD)
Updated Oct 23, 2026
5-Year Average Dividend Yield
0.28%
vs all stocks
Updated Oct 23, 2026
Payout Ratio
10.00%
vs Medical Care Facilities peers
Updated Oct 23, 2026
Minority Interest (Equity)
1.78BCNYFY2025 · Dec 31, 2025
Revenue
6.36BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
3.79BCNYFY2025 · Dec 31, 2025
Gross Profit
2.57BCNYFY2025 · Dec 31, 2025
Operating Income
450.02MCNY
67.41M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-673.94MCNYFY2025 · Dec 31, 2025
Income Tax Expense
57.96MCNYFY2025 · Dec 31, 2025
Net Income
-731.90MCNYFY2025 · Dec 31, 2025
EBIT
-618.92MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
898.58MCNYFY2025 · Dec 31, 2025
Research & Development
230.73MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
719.57MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
105.78MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
105.69MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
55.02MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.6300CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.6300CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
1.34BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
1.34BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-731.90MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-109.80MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-922.19MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-1.27BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
5.48BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-731.90MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
194.13MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-136.41MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-248.00MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-343.36MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-8.86MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-944.45MCNYFY2025 · Dec 31, 2025
Sale of Investments
1.48BCNYFY2025 · Dec 31, 2025
Other Investing Activity
20.00MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
205.96MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
282.86MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-427.56MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-85.39MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-22.16MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-252.25MCNYFY2025 · Dec 31, 2025
Shares Outstanding
1.35BSharesUpdated Oct 23, 2026
Float Shares
609.78MSharesUpdated Oct 23, 2026
% Held by Insiders
55.17%
vs all stocks
Updated Oct 23, 2026
% Held by Institutions
1.75%
vs all stocks
Updated Oct 23, 2026
Total Cash (MRQ)
6.11BCNY
914.96M · vs all stocks (USD)
Updated Oct 23, 2026
Total Cash per Share (MRQ)
4.54CNYUpdated Oct 23, 2026
Total Debt (MRQ)
954.74MCNY
143.02M · vs all stocks (USD)
Updated Oct 23, 2026
Total Debt to Equity (MRQ)
0.0524x
vs Medical Care Facilities peers
Updated Oct 23, 2026
Current Ratio (MRQ)
1.49x
vs Medical Care Facilities peers
Updated Oct 23, 2026
Book Value per Share (MRQ)
12.17CNYUpdated Oct 23, 2026
Total Assets
25.38BCNY
3.80B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
9.01BCNYFY2025 · Dec 31, 2025
Total Liabilities
7.08BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
16.36BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.03BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
6.05BCNYFY2025 · Dec 31, 2025
Cash
5.47BCNYFY2025 · Dec 31, 2025
Cash Equivalents
21.72MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
5.49BCNYFY2025 · Dec 31, 2025
Other Short-term Investments
585.37MCNYFY2025 · Dec 31, 2025
Accounts Receivable
1.23BCNYFY2025 · Dec 31, 2025
Inventory
830.86MCNYFY2025 · Dec 31, 2025
Accounts Payable
857.38MCNYFY2025 · Dec 31, 2025
Short-term Debt
472.98MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
36.64MCNYFY2025 · Dec 31, 2025
Long-term Debt
478.70MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
31.86MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
1.35BCNYFY2025 · Dec 31, 2025
Retained Earnings
5.60BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
18.30BCNY
2.74B · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
5.07CNYUpdated Oct 23, 2026
52-Week High
9.58CNYUpdated Oct 23, 2026
52-Week Change
-29.84%
vs all stocks
Updated Oct 23, 2026
Beta
0.0830x
vs all stocks
Updated Oct 23, 2026
50-Day MA
5.72CNYUpdated Oct 23, 2026
200-Day MA
6.32CNYUpdated Oct 23, 2026
Avg 10-Day Volume
12.37MSharesUpdated Oct 23, 2026
Avg 30-Day Volume
17.84MSharesUpdated Oct 23, 2026
Diluted EPS (TTM)
-0.7200CNYUpdated Oct 23, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
Where is this company structurally exposed?
Diagnostic
Inverse RSI (1Y) Elevated With Four-Year Net Income And Gross Profit Decreases
The price reads stretched low, and net income and gross profit have fallen four years.
Reads
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Profit margin is -16.1%, lower than 95% of its Medical Care Facilities peers (median 4.2%)Significant
Inverse RSI (1Y) Elevated With Four-Year Net Income And Gross Profit DecreasesDown-Close Share With Multi-Year Earnings DecreaseMulti-Year Debt Decrease With Cash Near Total Debt And Equity